Company intelligence
Hugel Aesthetics
About Hugel Aesthetics
Founded in 2001, Hugel is a South Korea–based global leader in medical aesthetics, specializing in the development and commercialization of botulinum toxin, hyaluronic acid fillers, skin boosters, threads, and biocosmetics. Over the past two decades, Hugel has built a strong global footprint, with commercial presence in approximately 70 countries and operations across nine international subsidiaries. Leveraging strong global momentum, Hugel Aesthetics was formed as the Company’s dedicated North American business unit, established to lead commercialization in the United States, Canada and Australia. Backed by Hugel’s global scale and expertise, Hugel Aesthetics is a well-resourced, growth-oriented organization focused on expanding access to its flagship neurotoxin and establishing a strong, long-term presence in medical aesthetics.
Verified activity
Signals from Hugel Aesthetics
3 published signals
Presence & Recognition
Hugel Aesthetics expanded its presence by joining OLIVE YOUNG Festa LA to showcase Korean beauty innovation.
Reported by Hugel Aesthetics
Research & Knowledge
Hugel Aesthetics published the 2025 edition of the ASPS Annual Statistics Report, which confirms that 75% of surveyed surgeons named restoration after life changes as the leading reason patients seek plastic surgery.
Reported by Hugel Aesthetics
People
Hugel Aesthetics welcomed Alison Barnes as Senior Manager, Accounting.
Reported by Hugel Aesthetics